FDA Inspection
Qilu Antibiotics Pharmaceutical Co. , Ltd.Qilu Antibiotics Pharmaceutical Co. , Ltd. – FDA Inspection, Jul 16, 2026
Record Details
This FDA Inspection record concerns Qilu Antibiotics Pharmaceutical Co. , Ltd., with an inspection on July 16, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- July 16, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 7d9d4743-875c-4992-a37a-35fe116bf9bf
Inspection Facts
- Inspection number
- 1333262
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Qilu Antibiotics Pharmaceutical Co. , Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 30, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 16, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Qilu Antibiotics Pharmaceutical Co. , Ltd.
- FDA Inspection 1210065 - 2023-05-30
- FDA Inspection 1067678 - 2018-08-16
- FDA Inspection 945452 - 2015-09-22
- FDA Inspection 851836 - 2013-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.